Characterization of human and rodent native and recombinant adenosine A2B receptors by radioligand binding studies

Adenosine A2B receptors of native human and rodent cell lines were investigated using [3H]PSB-298 [(8-{4-[2-(2-hydroxyethylamino)-2-oxoethoxy]phenyl}-1-propylxanthine] in radioligand binding studies. [3H]PSB-298 showed saturable and reversible binding. It exhibited a KD value of 60 ± 1 nM and limited capacity (Bmax = 3.511 fmol per milligram protein) at recombinant human adenosine A2B receptors expressed in human embryonic kidney cells (HEK-293). The addition of sodium chloride (100 mM) led to a threefold increase in the number of binding sites recognized by the radioligand. The curve of the agonist 5′-N-ethylcarboxamidoadenosine (NECA) was shifted to the right in the presence of NaCl, while the curve of the antagonist PSB-298 was shifted to the left, indicating that PSB-298 may be an inverse agonist at A2B receptors. Adenosine A2B receptors were shown to be the major adenosine A2 receptor subtype on the mouse neuroblastoma x rat glioma hybrid cell line NG108-15 cells. Binding studies at rat INS-1 cells (insulin secreting cell line) demonstrated that [3H]PSB-298 is a selective radioligand for adenosine A2B binding sites in this cell line

Le signal en pharmacovigilance (méthodes et enjeux)

MONTPELLIER-BU Pharmacie (341722105) / SudocSudocFranceF

Utilisation de la caféine dans le traitement de l'apnée du nouveau-né prématuré

MONTPELLIER-BU Pharmacie (341722105) / SudocSudocFranceF

Anémie hémolytique et dextropropoxyphène (à propos d'un cas)

MONTPELLIER-BU Médecine UPM (341722108) / SudocMONTPELLIER-BU Médecine (341722104) / SudocSudocFranceF

Les résidus médicamenteux vétérinaires dans l'alimentation humaine (Réglementation. Risques. Surveillance sanitaire. Illustration par deux cas cliniques)

MONTPELLIER-BU Pharmacie (341722105) / SudocSudocFranceF

Les fluoroquinolones (profil de tolérance et relation structure-activité)

MONTPELLIER-BU Pharmacie (341722105) / SudocSudocFranceF

Insuffisances rénales aigües et prises médicamenteuses (enquête à partir de la Banque de Pharmacovigilance)

MONTPELLIER-BU Pharmacie (341722105) / SudocSudocFranceF